TRAM Snapshot of App at Pub for Oppostn

STRANDSMART

StrandSmart, Inc.

TRAM Snapshot of App at Pub for Oppostn

Trademark Snap Shot Publication Stylesheet
(Table presents the data on Publication Approval)

OVERVIEW

SERIAL NUMBER 88355281 FILING DATE 03/25/2019
REG NUMBER 0000000 REG DATE N/A
REGISTER PRINCIPAL MARK TYPE TRADEMARK
INTL REG # N/A INTL REG DATE N/A
TM ATTORNEY LAWRENCE, SUSAN KASTRI
L.O. ASSIGNED 116

PUB INFORMATION

RUN DATE 01/30/2020
PUB DATE N/A
STATUS 680-APPROVED FOR PUBLICATION
STATUS DATE 01/29/2020
LITERAL MARK ELEMENT STRANDSMART

DATE ABANDONED N/A DATE CANCELLED N/A
SECTION 2F NO SECTION 2F IN PART NO
SECTION 8 NO SECTION 8 IN PART NO
SECTION 15 NO REPUB 12C N/A
RENEWAL FILED NO RENEWAL DATE N/A
DATE AMEND REG N/A


FILING BASIS

FILED BASIS CURRENT BASIS AMENDED BASIS
1 (a) NO 1 (a) NO 1 (a) NO
1 (b) YES 1 (b) YES 1 (b) NO
44D NO 44D NO 44D NO
44E NO 44E NO 44E NO
66A NO 66A NO

NO BASIS NO NO BASIS NO


MARK DATA

STANDARD CHARACTER MARK YES
LITERAL MARK ELEMENT STRANDSMART
MARK DRAWING CODE 4-STANDARD CHARACTER MARK
COLOR DRAWING FLAG NO

CURRENT OWNER INFORMATION

PARTY TYPE 10-ORIGINAL APPLICANT
NAME StrandSmart, Inc.
ADDRESS c/o Adrianna Davies
100 Van Ness, Suite 1612
San Francisco, CA 94102
ENTITY 03-CORPORATION
CITIZENSHIP Delaware

GOODS AND SERVICES

INTERNATIONAL CLASS 005
          DESCRIPTION TEXT Diagnostic testing devices, namely, diagnostic kits comprised of a cartridge with microelectrodes therein, each microelectrode having a carbon nanotube film with cancer-specific antibodies or other targeting materials thereon for testing blood samples for detection of cancers, specifically breast cancer, colon cancer, lung cancer, pancreatic cancer and prostate cancer; Diagnostic kits comprised of cartridges with microelectrodes therein, each microelectrode having a carbon nanotube film with cancer-specific antibodies or other targeting materials thereon for use with an analysis device for testing of blood for detecting cancers in blood samples, specifically breast cancer, colon cancer, lung cancer, pancreatic cancer and prostate cancer
INTERNATIONAL CLASS 010
          DESCRIPTION TEXT Medical devices, namely, diagnostic kits consisting primarily of apparatus with microelectrodes therein, each microelectrode having a carbon nanotube film for use with cancer-specific antibodies or other targeting materials thereon, for analyzing blood samples for detecting cancers in blood samples, specifically breast cancer, colon cancer, lung cancer, pancreatic cancer and prostate cancer; Diagnostic testing devices, namely, diagnostic kits comprised of apparatus with microelectrodes therein, each microelectrode having a carbon nanotube film for use with cancer-specific antibodies or other targeting materials thereon, and an analysis device for testing blood samples for detection of cancers, specifically breast cancer, colon cancer, lung cancer, pancreatic cancer and prostate cancer

GOODS AND SERVICES CLASSIFICATION

INTERNATIONAL CLASS 005 FIRST USE DATE NONE FIRST USE IN COMMERCE DATE NONE CLASS STATUS 6-ACTIVE
INTERNATIONAL CLASS 010 FIRST USE DATE NONE FIRST USE IN COMMERCE DATE NONE CLASS STATUS 6-ACTIVE

MISCELLANEOUS INFORMATION/STATEMENTS

CHANGE IN REGISTRATION NO
PSEUDO MARK STRAND SMART

PROSECUTION HISTORY

DATE ENT CD ENT TYPE DESCRIPTION ENT NUM
01/29/2020 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER 018
01/29/2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED 017
01/29/2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE 016
01/28/2020 ALIE A ASSIGNED TO LIE 015
01/21/2020 ERFR I TEAS REQUEST FOR RECONSIDERATION RECEIVED 014
12/17/2019 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED 013
12/17/2019 GNFR O FINAL REFUSAL E-MAILED 012
12/17/2019 CNFR R FINAL REFUSAL WRITTEN 011
12/05/2019 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED 010
12/04/2019 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE 009
12/04/2019 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED 008
12/04/2019 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED 007
06/04/2019 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED 006
06/04/2019 GNRT F NON-FINAL ACTION E-MAILED 005
06/04/2019 CNRT R NON-FINAL ACTION WRITTEN 004
06/04/2019 DOCK D ASSIGNED TO EXAMINER 003
04/11/2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM 002
03/28/2019 NWAP I NEW APPLICATION ENTERED IN TRAM 001

CURRENT CORRESPONDENCE INFORMATION

ATTORNEY Raymond Van Dyke
CORRESPONDENCE ADDRESS Raymond Van Dyke
VAN DYKE LAW
WASHINGTON SQUARE, PO BOX 65302
1050 CONNECTICUT AVENUE NW
WASHINGTON DC 20035
DOMESTIC REPRESENTATIVE NONE

TRAM Snapshot of App at Pub for Oppostn [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed